EAEsteban Aliaga

Esteban Aliaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Esteban Aliaga has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Jenny Lucy Fiedler

    Laboratory of Neuroplasticity and Neurogenetics, Department of Biochemistry and Molecular Biology, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Independencia, Chile

    7 shared publications
  • Felipe Ignacio Aguayo

    Molecular Endocrinology Group, Signal Transduction Laboratory, NIEHS, NIH, DHHS, 111 TW Alexander Drive, RTP, NC 27709

    5 shared publications
  • Gonzalo García-Rojo

    Laboratory of Neuroplasticity and Neurogenetics, Faculty of Chemical and Pharmaceutical Sciences, Department of Biochemistry and Molecular Biology, Universidad de Chile, Independencia, 8380492, Santiago, Chile

    4 shared publications
  • Paulina S. Rojas

    Escuela de Química y Farmacia, Facultad de Medicina, Universidad Andres Bello, Santiago, Chile

    4 shared publications
  • Felipe Antonio Olave

    Laboratory of Neuroplasticity and Neurogenetics, Faculty of Chemical and Pharmaceutical Sciences, Department of Biochemistry and Molecular Biology, Universidad de Chile, Independencia, 8380492, Santiago, Chile

    3 shared publications
  • Gonzalo Bustos

    Laboratory of Biochemical Pharmacology, Department of Cell and Molecular Biology, Catholic University of Chile, Alameda 340, Santiago 114-D, Chile

    3 shared publications

Latest Publications

  • Open Access

    LACKING OF KINEMATIC CONTEXTUAL DISCRIMINATION IN NON-SOCIAL BEHAVIORAL TESTS AND DORSAL HIPPOCAMPUS-MTOR IMMUNOREACTIVITY ARE MAINTAINED IN PRENATAL VALPROATE-TREATED RATS

    by Esteban Aliaga, Catherine Mac-Rae, Katherine Morgado-Gallardo, Francisco Peralta, Carla Villagra, Jenny Fiedler

  • Open Access

    Deletion of hippocampal Glucocorticoid receptors unveils sex-biased microRNA expression and neuronal morphology alterations in mice

    by Macarena Tejos-Bravo, Robert H. Oakley, Shannon D. Whirledge, Wladimir A. Corrales, Juan P. Silva, Gonzalo García-Rojo, Jorge Toledo, Wendy Sanchez, Luciano Román-Albasini, Esteban Aliaga, et al.


  • Open Access

    Antidepressant-relevant behavioral and synaptic molecular effects of long-term fasudil treatment in chronically stressed male rats

    by Luciano Román-Albasini, Gabriela Díaz-Véliz, Felipe Antonio Olave, Felipe Ignacio Aguayo, Gonzalo García-Rojo, Wladimir Antonio Corrales, Juan Pablo Silva, Ana María Ávalos, Paulina S. Rojas, Esteban Aliaga, et al.


  • Dual effect of serotonin on the dendritic growth of cultured hippocampal neurons: Involvement of 5-HT1A and 5-HT7 receptors

    by P.S. Rojas, F. Aguayo, D. Neira, M. Tejos, E. Aliaga, J.P. Muñoz, C.S. Parra, J.L. Fiedler


  • Open Access

    Chronic Stress Triggers Expression of Immediate Early Genes and Differentially Affects the Expression of AMPA and NMDA Subunits in Dorsal and Ventral Hippocampus of Rats

    by Anibal Pacheco, Felipe I. Aguayo, Esteban Aliaga, Mauricio Muñoz, Gonzalo García-Rojo, Felipe A. Olave, Nicolas A. Parra-Fiedler, Alexandra García-Pérez, Macarena Tejos-Bravo, Paulina S. Rojas, et al.

    Previous studies in rats have demonstrated that chronic restraint stress triggers anhedonia, depressive-like behaviors, anxiety and a reduction in dendritic spine density in hippocampal neurons. In this study, we compared the effect of repeated stress on the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptor subunits in dorsal and ventral hippocampus. Adult male Sprague-Dawley rats were randomly divided into control and stressed groups, and were daily restrained in their motion (2.5 h/day) during 14 days. We found that chronic stress promotes an increase in cFOS mRNA levels in both hippocampal areas, although it was observed a reduction in the immunoreactivity at pyramidal cell layer. Furthermore, Arc mRNAs levels were increased in both dorsal and ventral hippocampus, accompanied by an increase in Arc immunoreactivity in dendritic hippocampal layers. Furthermore, stress triggered a reduction in PSD-95 and NR1 protein levels in whole extract of dorsal and ventral hippocampus. Moreover, a reduction in NR2A/NR2B ratio was observed only in dorsal pole. In synaptosomal fractions, we detected a rise in NR1 in dorsal hippocampus. By indirect immunofluorescence we found that NR1 subunits rise, especially in neuropil areas of dorsal, but not ventral hippocampus. In relation to AMPA receptor subunits, chronic stress did not trigger any change, either in dorsal or ventral hippocampal areas. These data suggest that dorsal hippocampus is more sensitive than ventral hippocampus to chronic stress exposure, mainly altering the expression of NMDA receptor subunits, and probably favors changes in the configuration of this receptor that may influence the function of this area.


  • Open Access

    The ROCK Inhibitor Fasudil Prevents Chronic Restraint Stress-Induced Depressive-Like Behaviors and Dendritic Spine Loss in Rat Hippocampus

    by Gonzalo García-Rojo, Cristóbal Fresno, Natalia Vilches, Gabriela Díaz-Véliz, Sergio Mora, Felipe Aguayo, Aníbal Pacheco, Nicolás Parra-Fiedler, Claudio S. Parra, Paulina S. Rojas, et al.

    Dendritic arbor simplification and dendritic spine loss in the hippocampus, a limbic structure implicated in mood disorders, are assumed to contribute to symptoms of depression. These morphological changes imply modifications in dendritic cytoskeleton. Rho GTPases are regulators of actin dynamics through their effector Rho kinase. We have reported that chronic stress promotes depressive-like behaviors in rats along with dendritic spine loss in apical dendrites of hippocampal pyramidal neurons, changes associated with Rho kinase activation. The present study proposes that the Rho kinase inhibitor Fasudil may prevent the stress-induced behavior and dendritic spine loss. Adult male Sprague-Dawley rats were injected with saline or Fasudil (i.p., 10 mg/kg) starting 4 days prior to and maintained during the restraint stress procedure (2.5 h/d for 14 days). Nonstressed control animals were injected with saline or Fasudil for 18 days. At 24 hours after treatment, forced swimming test, Golgi-staining, and immuno-western blot were performed. Fasudil prevented stress-induced immobility observed in the forced swimming test. On the other hand, Fasudil-treated control animals showed behavioral patterns similar to those of saline-treated controls. Furthermore, we observed that stress induced an increase in the phosphorylation of MYPT1 in the hippocampus, an exclusive target of Rho kinase. This change was accompanied by dendritic spine loss of apical dendrites of pyramidal hippocampal neurons. Interestingly, increased pMYPT1 levels and spine loss were both prevented by Fasudil administration. Our findings suggest that Fasudil may prevent the development of abnormal behavior and spine loss induced by chronic stress by blocking Rho kinase activity.


  • Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats

    by Francisco Peralta, Constanza Fuentealba, Jenny Fiedler, Esteban Aliaga

    Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications


  • Association of N‐cadherin levels and downstream effectors of Rho GTPases with dendritic spine loss induced by chronic stress in rat hippocampal neurons

    by Patricia Castañeda, Mauricio Muñoz, Gonzalo García‐Rojo, José L. Ulloa, Javier A. Bravo, Ruth Márquez, M. Alexandra García‐Pérez, Damaris Arancibia, Karina Araneda, Paulina S. Rojas, et al.

    Chronic stress promotes cognitive impairment and dendritic spine loss in hippocampal neurons. In this animal model of depression, spine loss probably involves a weakening of the interaction between pre‐ and postsynaptic cell adhesion molecules, such as N‐cadherin, followed by disruption of the cytoskeleton. N‐cadherin, in concert with catenin, stabilizes the cytoskeleton through Rho‐family GTPases. Via their effector LIM kinase (LIMK), RhoA and ras‐related C3 botulinum toxin substrate 1 (RAC) GTPases phosphorylate and inhibit cofilin, an actin‐depolymerizing molecule, favoring spine growth. Additionally, RhoA, through Rho kinase (ROCK), inactivates myosin phosphatase through phosphorylation of the myosin‐binding subunit (MYPT1), producing actomyosin contraction and probable spine loss. Some micro‐RNAs negatively control the translation of specific mRNAs involved in Rho GTPase signaling. For example, miR‐138 indirectly activates RhoA, and miR‐134 reduces LIMK1 levels, resulting in spine shrinkage; in contrast, miR‐132 activates RAC1, promoting spine formation. We evaluated whether N‐cadherin/β‐catenin and Rho signaling is sensitive to chronic restraint stress. Stressed rats exhibit anhedonia, impaired associative learning, and immobility in the forced swim test and reduction in N‐cadherin levels but not β‐catenin in the hippocampus. We observed a reduction in spine number in the apical dendrites of CA1 pyramidal neurons, with no effect on the levels of miR‐132 or miR‐134. Although the stress did not modify the RAC–LIMK–cofilin signaling pathway, we observed increased phospho‐MYPT1 levels, probably mediated by RhoA–ROCK activation. Furthermore, chronic stress raises the levels of miR‐138 in accordance with the observed activation of the RhoA–ROCK pathway. Our findings suggest that a dysregulation of RhoA–ROCK activity by chronic stress could potentially underlie spine loss in hippocampal neurons.


  • Review article: intestinal barrier dysfunction and central nervous system disorders - a controversial association

    by M. Julio-Pieper, J. A. Bravo, E. Aliaga, M. Gotteland

    Central nervous system (CNS) development and physiopathology are greatly affected by environmental stimuli. The intestinal barrier restricts the entrance of toxins, pathogens, and antigens while modulating the expression of various neuroactive compounds. The existence of a rich gut-to-brain communication raises the possibility that intestinal barrier alterations may take part in the pathophysiology of CNS disorders. To review evidence associating intestinal barrier dysfunction with the development of CNS disorders. Literature search was conducted on PubMed using the following terms: intestinal barrier, intestinal permeability, central nervous system, mental disorders, schizophrenia, autism, stress, anxiety, depression, and neurodegeneration. Clinical and animal model studies of the association between intestinal barrier and schizophrenia, autism spectrum disorders, neurodegenerative diseases or depression were reviewed. The majority of reports concentrated on schizophrenia and autism spectrum disorders. About half of these described increased intestinal permeability/mucosal damage in patients compared with healthy controls, with up to 43% of children with autism spectrum disorders and up to 35% of schizophrenia patients displaying abnormally high urinary excretion of the sugars used as permeability markers. However, another substantial group of studies did not find such differences. In autism spectrum disorders, some reports show that the use of diets such as the gluten-free casein-free diet may contribute to the normalisation of lactulose/mannitol ratio, but to date there is no adequately controlled study showing improvement in behavioural symptoms following these dietary interventions. Evidence of altered intestinal permeability in individuals suffering from CNS disorders is limited and cannot be regarded as proven. Moreover the efficacy of targeting gut barrier in the management of neurological and behavioural aspects of CNS disorders has not yet been established, and needs further investigation.


  • Hypothyroidism in the Adult Rat Causes Incremental Changes in Brain-Derived Neurotrophic Factor, Neuronal and Astrocyte Apoptosis, Gliosis, and Deterioration of Postsynaptic Density

    by Claudia Cortés, Eliseo Eugenin, Esteban Aliaga, Leandro J. Carreño, Susan M. Bueno, Pablo A. Gonzalez, Silvina Gayol, David Naranjo, Verónica Noches, Michelle P. Marassi, et al.

    Background: Adult hypothyroidism is a highly prevalent condition that impairs processes, such as learning and memory. Even though tetra-iodothyronine (T 4 ) treatment can overcome the hypothyroidism in the majority of cases, it cannot fully recover the patient's learning capacity and memory. In this work, we analyzed the cellular and molecular changes in the adult brain occurring with the development of experimental hypothyroidism. Methods: Adult male Sprague-Dawley rats were treated with 6-propyl-2-thiouracil (PTU) for 20 days to induce hypothyroidism. Neuronal and astrocyte apoptosis were analyzed in the hippocampus of control and hypothyroid adult rats by confocal microscopy. The content of brain-derived neurotrophic factor (BDNF) was analyzed using enzyme-linked immunosorbent assay (ELISA) and in situ hybridization. The glutamatergic synapse and the postsynaptic density (PSD) were analyzed by electron microscopy. The content of PSD proteins like tyrosine receptor kinase B (TrkB), p75, and N-methyl- d -aspartate receptor (NMDAr) were analyzed by immunoblot. Results: : We observed that the hippocampus of hypothyroid adult rats displayed increased apoptosis levels in neurons and astrocyte and reactive gliosis compared with controls. Moreover, we found that the amount of BDNF mRNA was higher in the hippocampus of hypothyroid rats and the content of TrkB, the receptor for BDNF, was reduced at the PSD of the CA3 region of hypothyroid rats, compared with controls. We also observed that the glutamatergic synapses from the stratum radiatum of CA3 from hypothyroid rats, contained thinner PSDs than control rats. This observation was in agreement with a reduced content of NMDAr subunits at the PSD in hypothyroid animals. Conclusions: Our data suggest that adult hypothyroidism affects the hippocampus by a mechanism that alters the composition of PSD, reduces neuronal and astrocyte survival, and alters the content of the signaling neurotrophic factors, such as BDNF.